Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Premium

Register

Sign In

EUR/USD

1.2104

-0.0002

-0.01%

GBP/USD

1.3913

-0.0003

-0.02%

USD/JPY

109.29

-0.0595

-0.05%

USD/CHF

0.9895

0.0004

0.04%

EUR/GBP

0.8700

0.0001

0.01%

USD/CAD

1.2880

0.0006

0.05%

NZD/USD

0.7055

-0.0003

-0.04%

EUR/JPY

132.29

-0.0915

-0.07%

EUR/CHF

1.1978

0.0003

0.03%

Juno Therapeutics Inc

NASDAQ: JUNOHealthcare / Biotechnology / USA
86.96+0.09+0.10%Vol 3 696 1001Y Perf 302.41%
Mar 5th, 2018 19:15
BID0.00 ASK0.00
Open86.97 Previous Close86.87
Pre-Market- After-Trading-
 - -%  - -%
Target Price
72.00 
Analyst Rating
Hold 2.73
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-85 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-95 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-90 
Income Ranking
 —    -
Market Cap (mil)10 097 
Earnings Rating
Price Range Ratio 52wk %
0.00 
Earnings Date

Today's Price Range

86.9087.01

 

52wk Range

19.6287.01

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
0.00%
3 Months
1.45%
6 Months
90.20%
1 Year
302.41%
3 Years
71.15%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
JUNO86.960.09000.10
AAPL164.220.57000.35
GOOG1 040.0418.86001.85
MSFT94.261.95002.11
XOM80.861.36001.71
WFC52.44-0.6700-1.26
JNJ128.011.25000.99
FB174.1614.47009.06
GE14.380.33002.35
JPM110.100.11000.10
...

TickerPriceChg.%52 Week High
CMG422.5024.44499.00
ALXN121.4214.50149.34
AMD11.0413.7015.65
ORLY257.4013.06279.23
FB174.169.06195.32
EQT50.948.5067.84
TSCO66.667.1982.68
KIM14.076.2721.85
ABBV97.446.06125.86
ALGN259.895.81287.32
MU50.145.3463.42
BAX69.995.2272.58
INTU185.185.00186.39
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.50
Current Ratio 3.60
Long Term Debt to Total Capital 0.01
Total Debt to Equity 0.01
Interest Coverage -
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-448.50
EBITDA Margin-417.30
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 9.64
PS Ratios 90.25
Price to Cash Flow 97.50
Price to Free Cash Flow -35.30
Cash Flow Per Share -2.11
Price to Tangible Book13.45
Book Value per Share9.02
Enterprise Value (in ths.)9 380 340
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-34.37
ROE last 12 Months -38.40
Return on Assets (5Y Avg) -17.96
ROA last 12 Months -29.39
Return on Capital (5Y Avg) -
ROC last 12 Months -33.72
Return on invested Capital Q -12.28
Return on invested Capital Y-40.76
Assets Turnover0.10
Receivables Turnover6.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)111 871
Revenue per Share 0.96
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017-0.88-1.12-27.27
Q02 2017-0.74-0.75-1.35
Q01 2017-0.66-0.72-9.09
Q04 2016-0.63-0.66-4.76
Q03 2016-0.64-0.589.38
Q02 2016-0.51-0.65-27.45
Q01 2016-0.67-0.79-17.91
Q04 2015-0.54-0.540.00
Earnings Per EndEstimateRevision %Trend
12/2017 QR-1.13-10.78Negative
12/2017 FY-4.020.00-
3/2018 QR-1.24-21.57Negative
12/2018 FY-4.83-9.77Negative
Next Report Date7th Mar 2018
Estimated EPS Next Report-1.02
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume3 696 100
Shares Outstanding (in ths.)116 110
Trades Count0
Dollar Volume0
Avg. Volume5 484 542
Avg. Weekly Volume2 593 720
Avg. Monthly Volume4 145 455
Avg. Quarterly Volume4 738 303

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

83%17%

Bearish Bullish

86%14%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (9.09 %)
1 (8.33 %)
7 (63.64 %)
Moderate Buy
1 (9.09 %)
1 (8.33 %)
1 (9.09 %)
Hold
9 (81.82 %)
10 (83.33 %)
3 (27.27 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
2.73
Hold
2.75
Moderate Buy
1.64

There are no comments yet.

News

x